Pseudomonilethrix type II and pili bifurcati

JEADV 2006, 20, 868–902 © 2006 European Academy of Dermatology and Venereology 889 4 Beasley KL, Cooley GE, Kao GF, Lowitt MH, Burnett JW, Aurelian L. Herpes simplex vegetans: atypical genital herpes infection in a patient with common variable immunodeficiency. J Am Acad Dermatol 1997; 37: 860–863. 5 Samaratunga H, Weedon D, Musgrave N, McCallum N. Atypical presentation of herpes simplex (chronic hypertrophic herpes) in a patient with HIV infection. Pathology 2001; 33: 532–535. 6 Fangman WL, Rao CH, Myers SA. Hypertrophic herpes simplex virus in HIV patients. J Drugs Dermatol 2003; 2: 198–201. 7 Fox PA, Barton SE, Francis N et al. Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease. HIV Med 1999; 1: 10–18. 8 Fife KH, Crumpacker CS, Mertz GJ, Hill EL, Boone GS. Recurrence and resistance patterns of herpes simplex virus following cessation of > or = 6 years of chronic suppression with acyclovir. Acyclovir Study Group. J Infect Dis 1994; 169: 1338–1341. 9 Pechère M, Wunderli W, Trellu-Toutous L, Harms M, Saurat JH, Krischer J. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis. Dermatology 1998; 197: 278–280. 10 Bevilacqua F, Marcello A, Toni M et al. Acyclovir resistance/ susceptibility in herpes simplex virus type 2 sequential isolates from an AIDS patient. J Acquir Immune Defic Syndr 1991; 4: 967–969.